• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含马兜铃酸的中草药与台湾地区上泌尿道尿路上皮癌:一篇叙述性评论。

Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.

机构信息

Departments of Pharmacological Sciences and Medicine, Stony Brook University, Stony Brook, NY, USA.

Department of Urology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, 100, Taiwan, ROC.

出版信息

World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22.

DOI:10.1007/s00345-022-04100-5
PMID:35867141
Abstract

PURPOSE

The high incidence of upper urinary tract urothelial carcinoma (UTUC) in Taiwan is largely due to exposure to aristolochic acid (AA), a principal component of Aristolochia-based herbal medicines. Here we systematically review the molecular epidemiology, clinical presentation and biomarkers associated with AA-induced UTUC.

METHODS

This is a narrative review. Medline, Embase, and Web of Science were searched from inception to December 31, 2021. Studies evaluating the association, detection, and clinical characteristics of AA and UTUC were included.

RESULTS

A nationwide database revealed 39% of the Taiwanese population had been exposed to AA-containing herbs between 1997 and 2003. Epidemiological reports revealed AA posed a significantly higher hazard for renal failure and UTUC in herbalists and the general population who ingested AA-containing herbs. The presence of aristolactam-DNA adducts and a distinctive signature mutation, A:T to T:A transversions, located predominantly on the non-transcribed DNA strand, with a strong preference for deoxyadenosine in a consensus sequence (CAG), was observed in many UTUC patients. Clinically, AA-related UTUC patients were characterized by a younger age, female gender, impaired renal function and recurrence of contralateral UTUC. To date, there are no preventive measures, except prophylactic nephrectomy, for subjects at risk of AA nephropathy or AA-related UTUC.

CONCLUSION

AA exposure via Aristolochia-based herbal medicines is a problem throughout Taiwan, resulting in a high incidence of UTUC. Aristolactam-DNA adducts and a distinctive signature mutation, A:T to T:A transversions, can be used as biomarkers to identify AA-related UTUC. AA-related UTUC is associated with a high recurrence rate of contralateral UTUC.

摘要

目的

台湾地区上尿路尿路上皮癌(UTUC)发病率较高,主要与摄入马兜铃酸(AA)有关,AA 是马兜铃属草药的主要成分之一。本文系统综述了与 AA 相关的 UTUC 的分子流行病学、临床表现和生物标志物。

方法

这是一篇叙述性综述。检索了 Medline、Embase 和 Web of Science 数据库,检索时间截至 2021 年 12 月 31 日。纳入评估 AA 与 UTUC 之间关联、检测和临床特征的研究。

结果

一项全国性数据库显示,1997 年至 2003 年期间,39%的台湾居民接触过含 AA 的草药。流行病学报告显示,草药师和摄入含 AA 草药的一般人群中,AA 显著增加了肾衰竭和 UTUC 的发病风险。在许多 UTUC 患者中观察到存在aristolactam-DNA 加合物和特征性突变,即 A:T 到 T:A 颠换,主要位于非转录 DNA 链上,在强 CAG 一致性序列中强烈偏好脱氧腺苷。临床上,AA 相关 UTUC 患者的特征为年龄较小、女性、肾功能受损和对侧 UTUC 复发。迄今为止,除预防性肾切除术外,对于有发生 AA 肾病或 AA 相关 UTUC 风险的人群,尚无其他预防措施。

结论

台湾地区普遍存在通过马兜铃属草药摄入 AA 的问题,导致 UTUC 发病率较高。aristolactam-DNA 加合物和特征性突变 A:T 到 T:A 颠换可用作识别 AA 相关 UTUC 的生物标志物。AA 相关 UTUC 与对侧 UTUC 高复发率相关。

相似文献

1
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.含马兜铃酸的中草药与台湾地区上泌尿道尿路上皮癌:一篇叙述性评论。
World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22.
2
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.台湾马兜铃酸相关性上尿路上皮癌:临床特征与结局。
Int J Cancer. 2013 Jul;133(1):14-20. doi: 10.1002/ijc.28013. Epub 2013 Feb 12.
3
Aristolochic acid-associated urothelial cancer in Taiwan.台湾的马兜铃酸相关性尿路上皮癌。
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8241-6. doi: 10.1073/pnas.1119920109. Epub 2012 Apr 9.
4
Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.砷和马兜铃酸在化学致癌作用于上尿路尿路上皮的协同作用。
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):317-325. doi: 10.1158/1055-9965.EPI-20-1090. Epub 2020 Dec 4.
5
Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.巴尔干地方性肾病与马兜铃酸的致病作用。
Semin Nephrol. 2019 May;39(3):284-296. doi: 10.1016/j.semnephrol.2019.02.007.
6
Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics.通过非靶向 DNA 加合物组学筛选大鼠肾脏和肝脏中的 DNA 损伤。
Chem Res Toxicol. 2024 Feb 19;37(2):340-360. doi: 10.1021/acs.chemrestox.3c00333. Epub 2024 Jan 9.
7
Aristolochic Acid in the Etiology of Renal Cell Carcinoma.马兜铃酸在肾细胞癌病因学中的作用
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1600-1608. doi: 10.1158/1055-9965.EPI-16-0219. Epub 2016 Aug 23.
8
Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center.肾输尿管切除术后新对侧上尿路尿路上皮癌的危险因素和治疗结果:来自一个大型中国中心的经验。
J Cancer Res Clin Oncol. 2014 Mar;140(3):477-85. doi: 10.1007/s00432-014-1585-7. Epub 2014 Jan 28.
9
Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.马兜铃酸突变特征定义了上尿路尿路上皮癌的低危亚型。
Theranostics. 2020 Mar 4;10(10):4323-4333. doi: 10.7150/thno.43251. eCollection 2020.
10
Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.马兜铃酸诱导的上尿路上皮癌的潜伏期。
Front Public Health. 2023 Mar 9;11:1072864. doi: 10.3389/fpubh.2023.1072864. eCollection 2023.

引用本文的文献

1
Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications.肠道微生物群与代谢产物:糖尿病及其并发症的生物标志物和治疗靶点
Nutrients. 2025 Aug 11;17(16):2603. doi: 10.3390/nu17162603.
2
L. Ethanolic Extracts: In Vitro Evaluation of Antioxidant Activity and Cytotoxicity on Caco-2 Cell Line.L. 乙醇提取物:对Caco-2细胞系抗氧化活性和细胞毒性的体外评估。
Plants (Basel). 2024 Oct 25;13(21):2987. doi: 10.3390/plants13212987.
3
Statin therapy and upper tract urothelial carcinoma risk in hyperlipidemic patients with chronic kidney disease and end-stage kidney disease, a population-based 17-year follow-up study.

本文引用的文献

1
Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.砷和马兜铃酸在化学致癌作用于上尿路尿路上皮的协同作用。
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):317-325. doi: 10.1158/1055-9965.EPI-20-1090. Epub 2020 Dec 4.
2
Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis.含马兜铃酸的中草药制品禁令后泌尿系统癌症发病率的降低:一项中断时间序列分析。
Sci Rep. 2019 Dec 27;9(1):19860. doi: 10.1038/s41598-019-56394-y.
3
Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients.
基于人群的 17 年随访研究:他汀类药物治疗与血脂异常的慢性肾脏病和终末期肾脏病患者上尿路尿路上皮癌风险
Ren Fail. 2024 Dec;46(2):2402508. doi: 10.1080/0886022X.2024.2402508. Epub 2024 Sep 20.
4
TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.TGFB1I1 促进膀胱癌中的细胞增殖和迁移。
Kaohsiung J Med Sci. 2024 Mar;40(3):269-279. doi: 10.1002/kjm2.12798. Epub 2024 Jan 5.
5
Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review.上尿路尿路上皮癌(UTUC)的诊断与风险分层:综述
Cancers (Basel). 2023 Oct 14;15(20):4987. doi: 10.3390/cancers15204987.
6
Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.二氢嘧啶酶样 3(DPYSL3)蛋白上调预示着尿路上皮癌预后不良。
BMC Cancer. 2023 Jun 28;23(1):599. doi: 10.1186/s12885-023-11090-z.
7
Epidemiology and screening for urologic cancers.泌尿系统癌症的流行病学与筛查
World J Urol. 2023 Apr;41(4):897-898. doi: 10.1007/s00345-023-04405-z.
8
Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid.具有马兜铃酸的复发性尿路上皮癌的突变特征和克隆相关性。
Front Oncol. 2022 Sep 14;12:990023. doi: 10.3389/fonc.2022.990023. eCollection 2022.
含马兜铃酸的草药在上尿路尿路上皮癌患者中诱发与性别相关的肿瘤差异。
Cancer Manag Res. 2018 Dec 4;10:6627-6639. doi: 10.2147/CMAR.S178554. eCollection 2018.
4
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.通过分析驱动基因突变和非整倍体进行尿路上皮癌的无创检测。
Elife. 2018 Mar 20;7:e32143. doi: 10.7554/eLife.32143.
5
Aristolochic Acid in the Etiology of Renal Cell Carcinoma.马兜铃酸在肾细胞癌病因学中的作用
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1600-1608. doi: 10.1158/1055-9965.EPI-16-0219. Epub 2016 Aug 23.
6
Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.血糖控制不佳的糖尿病会增加上尿路尿路上皮癌患者的膀胱癌复发风险。
Diabetes Metab Res Rev. 2015 Mar;31(3):307-14. doi: 10.1002/dmrr.2614. Epub 2014 Dec 5.
7
Increased risk of urothelial cancer in young and middle aged patients with end-stage renal disease.终末期肾病的中青年患者患尿路上皮癌的风险增加。
J Formos Med Assoc. 2015 Jan;114(1):52-7. doi: 10.1016/j.jfma.2013.10.022. Epub 2013 Dec 18.
8
Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.人类福尔马林固定石蜡包埋组织:通过质谱法进行致癌物 DNA 加合物生物监测的未开发标本。
Anal Chem. 2013 May 7;85(9):4251-8. doi: 10.1021/ac400612x. Epub 2013 Apr 10.
9
Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.职业性接触含马兜铃酸的草药会增加草药师患尿路上皮癌的风险。
J Urol. 2013 Jan;189(1):48-52. doi: 10.1016/j.juro.2012.08.090. Epub 2012 Nov 16.
10
Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.利用超高效液相色谱/离子阱质谱联用技术对人体组织中aristolactam-DNA 加合物进行生物监测。
Chem Res Toxicol. 2012 May 21;25(5):1119-31. doi: 10.1021/tx3000889. Epub 2012 May 4.